tradingkey.logo

Penumbra Inc

PEN
231.540USD
-1.830-0.78%
Cierre 10/30, 16:00ETCotizaciones retrasadas 15 min
9.02BCap. mercado
61.09P/E TTM

Más Datos de Penumbra Inc Compañía

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

Información de Penumbra Inc

Símbolo de cotizaciónPEN
Nombre de la empresaPenumbra Inc
Fecha de salida a bolsaSep 18, 2015
Director ejecutivoMr. Adam Elsesser, J.D.
Número de empleados4500
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 18
DirecciónOne Penumbra Place
CiudadALAMEDA
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal94502
Teléfono15109952486
Sitio Webhttps://www.penumbrainc.com/
Símbolo de cotizaciónPEN
Fecha de salida a bolsaSep 18, 2015
Director ejecutivoMr. Adam Elsesser, J.D.

Ejecutivos de Penumbra Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
51.68K
-1.15%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
26.96K
-4.58%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.82K
-1.03%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
51.68K
-1.15%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
26.96K
-4.58%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Thrombectomy
230.26M
67.83%
Embolization and Access
109.20M
32.17%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
260.82M
76.83%
International
78.64M
23.17%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Thrombectomy
230.26M
67.83%
Embolization and Access
109.20M
32.17%

Estadísticas de accionistas

Actualizado: mié., 22 de oct
Actualizado: mié., 22 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Investment Management (US)
3.00%
Otro
61.51%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Investment Management (US)
3.00%
Otro
61.51%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
60.23%
Investment Advisor/Hedge Fund
22.51%
Hedge Fund
5.08%
Individual Investor
3.73%
Pension Fund
1.88%
Research Firm
1.63%
Sovereign Wealth Fund
1.21%
Bank and Trust
0.52%
Private Equity
0.08%
Otro
3.13%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
844
36.41M
93.36%
-2.48M
2025Q2
864
37.32M
95.72%
-2.83M
2025Q1
878
36.92M
95.33%
-3.44M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
5.04M
12.92%
+93.97K
+1.90%
Jun 30, 2025
The Vanguard Group, Inc.
3.85M
9.88%
+185.31K
+5.05%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.61M
9.25%
+78.78K
+2.23%
Jun 30, 2025
T. Rowe Price Associates, Inc.
1.34M
3.44%
+164.55K
+13.99%
Jun 30, 2025
State Street Investment Management (US)
1.17M
3%
-26.92K
-2.25%
Jun 30, 2025
Elsesser (Adam)
1.02M
2.62%
+12.18K
+1.21%
Sep 03, 2025
Baillie Gifford & Co.
922.13K
2.36%
+233.13K
+33.84%
Jun 30, 2025
RTW Investments L.P.
863.55K
2.21%
+783.00
+0.09%
Jun 30, 2025
Fidelity Institutional Asset Management
818.24K
2.1%
-76.68K
-8.57%
Jun 30, 2025
Champlain Investment Partners, LLC
743.71K
1.91%
-126.21K
-14.51%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
Motley Fool Small-Cap Growth ETF
3.26%
Congress SMid Growth ETF
2.33%
SPDR S&P Health Care Equipment ETF
1.95%
First Trust Indxx Medical Devices ETF
1.84%
ROBO Global Healthcare Technology & Innovation ETF
1.71%
Invesco S&P MidCap Quality ETF
1.59%
Putnam Sustainable Future ETF
1.45%
iShares U.S. Medical Devices ETF
1.21%
First Trust Health Care Alphadex Fund
0.91%
Fidelity Women's Leadership ETF
0.78%
Ver más
Motley Fool Small-Cap Growth ETF
Proporción3.26%
Congress SMid Growth ETF
Proporción2.33%
SPDR S&P Health Care Equipment ETF
Proporción1.95%
First Trust Indxx Medical Devices ETF
Proporción1.84%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.71%
Invesco S&P MidCap Quality ETF
Proporción1.59%
Putnam Sustainable Future ETF
Proporción1.45%
iShares U.S. Medical Devices ETF
Proporción1.21%
First Trust Health Care Alphadex Fund
Proporción0.91%
Fidelity Women's Leadership ETF
Proporción0.78%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI